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Septic pelvic thrombophlebitis (SPT) was initially diagnosed and described in the late 1800’s. The entity had a high incidence and
mortality during this period of time, and a surgical therapeutic approach was the treatment of choice. Since then, the diagnosis,
incidence, and management of the entity evolved. This evolution followed the development of newer diagnostic tools such as com-
puted tomography (CT), magnetic resonance imaging (MRI), and a better understanding of the pathophysiology of the disease.
The treatment of SPT has had signiﬁcant changes as well, from a surgical approach at the end of the 19th century to a medical
approach after the 1960’s. By using an adequate broad-spectrum antibiotic therapy, mortality has decreased. However, controversy
in the management of this entity remains even till today.
Copyright © 2006 Javier Garcia et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
BACKGROUND
The entity of septic pelvic thrombophlebitis has evolved pro-
foundly over the last century. The bulk of cases in early re-
ports was mostly obstetric, with a signiﬁcant number of fol-
lowing abortions. Gynecologic cases with this complication
represented the minority.
By the end of the 19th century, von Recklinhausen de-
scribed an entity in which pelvic infection was character-
ized by thrombosis of one or both ovarian veins while the
remaining pelvis was normal, proposing surgical excision as
the therapeutic approach.
The ﬁrst successful cases of pelvic vein ligation as a treat-
ment for puerperal pyemia were reported between 1898 and
1902 by a number of German physicians including Bumm,
Freund, and Trendelenburg [1–3]. In 1951 Collins published
his experience with 202 women who underwent surgical in-
tervention andproposed apathogenic model forsuppurative
pelvic thrombophlebitis [4, 5].
The incidence of the disease has been dynamic; a clear
example is the experience at the Charity Hospital in New
Orleans, where between 1941 and 1969, Collins reported a
total of 202 cases. A later report (1974–1981) described only
three cases in the same institution [4, 5]. This observation
was similar to the experience gathered from Grady Memorial
Hospital and Emory University Hospital by Josey and Stag-
gers who determined the incidence to be 0.05 percent [6].
In the following decade (1980 to 1989), Dunnihoo et al cal-
culated a similar incidence [1]. Finally, in 1999, Brown and
colleagues published a ﬁve-year survey of patients delivered
at Parkland Hospital ﬁnding an overall incidence of 1 : 3000
deliveries. The incidence for vaginal delivery was 1 : 9000
compared to 1 : 800 for cesarean section [3].
Mortality has had a drastic change. Reviews by Williams
and Miller reported an average mortality of roughly 50%
during the ﬁrst quarter of the twentieth century in patients
undergoing surgery. Collins (1951) reported a 90% survival
aftertheligationofinferiorvenacavaandovarianveins.Dur-
ing the decade of the 1980’s, mortality was reported to be 4.4
percent [1].
In 1999 after following a total of 44922 deliveries, 69 pa-
tients carried the diagnosis of prolonged infection. Fifteen
patients were found to have pelvic thrombophlebitis, how-
ever, no complication or death was reported in either group
[3].
CASES
We report two cases which are typical of the eight cases in
which the diagnosis of septic pelvic thrombophlebitis was
suspected in the past two years. These cases highlight the risk
factors that may be associated to the development of septic
pelvic thrombophlebitis, the management, and treatment of
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Case1
A 28-year-old primigravid underwent a cesarean section sec-
ondary to having a breech presentation and rupture of mem-
branes at 36 weeks gestation. The cesarean section was un-
complicated,butonpostpartumdayonethepatientwashav-
ing fever and uterine tenderness. A diagnosis of postpartum
endometritiswasmadeandtheinfectionwastreatedwithEr-
tapenem1gintravenouslydaily.After48hoursofantibiotics,
the patient denied uterine tenderness and her WBC count
was12000/mm3.Nevertheless,thepatientcontinuedtospike
fevers and on postpartum day four an abdominal CT scan
was obtained. A right ovarian vein thrombosis was noted on
the imaging and the patient started therapeutic enoxaparin.
After 48 hours of anticoagulation, the patient was afebrile
and asymptomatic. The patient was discharged home after
being anticoagulated with warfarin and after 6 weeks a CT
scan was repeated. The right ovarian thrombosis was not
present in the images and warfarin was discontinued.
Case2
A 32-year-old patient underwent a successful in vitro fertil-
ization. At 25 weeks gestation the patient had preterm pre-
mature rupture of membranes. The patient was started on
penicillin G and a course of steroids was given. After 1 week
of expectant management, the patient started to have con-
tractions and a diagnostic amniocentesis was performed. An
intraamniotic infection was diagnosed and a classical ce-
sarean section was performed. The patient was started on
gentamicin and clindamycin intraoperatively. After 24 hours
of antibiotics, the patient continued to have fever and ampi-
cillin was added. On postpartum day 4, the patient com-
plained of pelvic pain and continued to have fever spikes
to 101 F. The patient’s urinalysis, urine, and blood cultures
were negative and her WBC count was 17000/mm3.T h e
patient was anticoagulated with enoxaparin after a clinical
diagnosis of septic pelvic thrombophlebitis that was sus-
pected and an abdominal CT scan was ordered. The CT
scan was negative, but after 24 hours of enoxaparin, the pa-
tient became afebrile and her pelvic pain diminished. After
2 days with enoxaparin a WBC count was repeated show-
ing a decrease to 12000/mm3. The patient was discharged
home on enoxaparin for another week and was followed in
clinic for her postoperative appointment. Her pelvic pain
was minimal and the rest of her recovery was uncompli-
cated.
Pathophysiology
The pathophysiology of pelvic thrombophlebitis as a pro-
gression of a pelvic infection was ﬁrst elucidated by Collins
and later Duﬀ, Gibbs, and others [1, 4, 5].
The pathogenesis is thought to include injury to the in-
tima of the pelvic vein caused by a spreading uterine infec-
tion, bacteremia, and endotoxins, which can also occur sec-
ondary to the trauma of delivery or surgery. In this setting,
Virchow’s triad is completed due to the contribution of preg-
nancy as a well-known hypercoagulable state, and the reduc-
tionofbloodﬂowindilateduterineandovarianveinsduring
the postpartum period which causes venous stasis. Phlebo-
graphic studies have demonstrated a left to right venous ﬂow
inuprightposition,whichmayexplainthedextro-prevalence
of ovarian vein thrombosis [1].
Diagnosticapproach
A suspicion of SPT should arise when fever, which usually
follows a spiking pattern, fails to respond to standard broad-
spectrum antibiotic therapy. Septic pelvic thrombophlebitis
was diagnosed in 20 percent of patients with prolonged
febrile morbidity, deﬁned as more than ﬁve days of fever re-
gardless of appropriate antimicrobial treatment [3].
Patients often complain of ﬂank and lower abdominal
pain, typically described as noncolicky and constant. Pain
may be of variable intensity and may radiate to the groin or
upper abdomen, and paralytic ileus may occur.
Upon physical examination, the patient usually does not
appear toxic, there may be tenderness to palpation in the
lower abdomen, and an occasional tender abdominal mass
described as rope or sausage-shape may be identiﬁed. This
represents the most diagnostic ﬁnding in an abdominal
exam, but it is rare.
Other clinical characteristics of septic pelvic throm-
bophlebitis have changed over time. Pulmonary emboli, was
considered a criterion for diagnosis of the condition. Initial
reports described pulmonary embolic phenomena to be fre-
quent, small, and multiple [4, 5, 7].
During the decades of the 1960’s through 1970’s, some
authors reported that 32 to 38 percent of patients with septic
pelvic thrombophlebitis had evidence of pulmonary emboli
[7]. Most of these diagnoses were made only on the basis of
radiographic ﬁndings. However, other contemporary inves-
tigators demonstrated an incidence of pulmonary embolism
in a range of 2.7%. The latest series (1999) did not report a
single embolic event after following up 44922 patients over a
3-year period [3]. Reﬁnements in the diagnostic methodol-
ogy as well as implementation of earlier and more eﬀective
treatment are likely the reasons responsible for the remark-
able decline in the incidence of embolic events.
Diagnostic tools like computed tomography (CT) and
magnetic resonance imaging (MRI) are used to provide con-
ﬁrmationofpelvicthrombophlebitis[1].Tomographiccrite-
riafordiagnosisinclude(1)enlargementoftheveininvolved,
(2) low density lumen within the vessel wall, and (3) sharp
enhancement of the vessel wall. When using MRI the throm-
bosed vessel will appear bright whereas normal blood ﬂow
looks dark.
It is believed that both methods are comparable. MRI of-
fers a better visualization of soft tissue changes, being able
to evaluate the resolution of edema and inﬂammatory signs.
However,bothtechniqueshavetheirlimitationsrelatedtovi-
sualizing smaller vessels such as uterine, cervical, and other
smaller pelvic branches.
Anecdotal experiences with pelvic ultrasound used for
the diagnosis of ovarian vein thrombosis revealed a limitedJavier Garcia et al 3
Table 1: Diagnosis and management for presumed septic pelvic thrombophlebitis.
CT or MRI ﬁndings Antibiotics Anticoagulation Length of treatment Final outcome
Right ovarian
vein thrombosis
Ertapenem or
gentamicin,
ampicillin,
clindamycin
(7 days)
Enoxaparin (1mg/Kg),
warfarin (INR 2.5) 3–6 months warfarin
Repeat CT scan
after 3 months.
If negative, stop
anticoagulation.
If still positive
for thrombi,
anticoagulate
for 3 additional
months
Pelvic branch
vein thrombosis
Ertapenem or
gentamicin,
ampicillin,
clindamycin
(7 days)
Enoxaparin (1mg/Kg) 2 weeks No repeat
imaging necessary
Negative for
pelvic thrombi
Ertapenem or
gentamicin,
ampicillin,
clindamycin
(7 days)
Enoxaparin (1mg/Kg) 1 week No repeat
imaging necessary
utility; nevertheless, ultrasonography may have a role in
monitoring treatment response [1].
Theonlylaboratorytestthatmayaidinthediagnosisand
management of the disease is a complete blood count with
blood cultures. Nevertheless, blood cultures provide identiﬁ-
cation of a microorganism in less than 35 percentof the cases
[1, 4, 5].
Managementandtreatment
By the turn of the century, surgical excision of the throm-
bosed vein was the treatment of choice [1]. After publish-
ing the experience at the Charity Hospital in New Orleans
in 1951, Collins advocated the ligature of the inferior vena
cava and ovarian veins as the optimal treatment reporting an
improvement in mortality rates after the procedure.
During the late sixties, heparin anticoagulation in con-
junction with antibiotic coverage gained general acceptance
and proved to be safe. These reports were observational, pa-
tient samples were small and heterogeneous, and the diag-
nosis of pelvic septic thrombophlebitis was presumptive in
most of the cases [7].
The absence of a deﬁnitive diagnostic technique made it
diﬃcult to corroborate a clinical suspicion and compare the
eﬀectiveness of treatment regimens proposed.
It was believed that the diagnosis of septic pelvic throm-
bophlebitis depended on a rapid return to normal tempera-
ture after heparin was given, an observation that is currently
being questioned.
In the last 20 years, the introduction of computed to-
mography and magnetic resonance imaging has revolution-
ized the diagnosis of pelvic thrombophlebitis allowing inves-
tigators to assess response to heparin therapy. Several obser-
vational studies questioning the eﬃcacy of anticoagulation
were followed by Brown and associates, who prospectively
gathered a total of 14 cases over a three-year period at Park-
land Hospital (Dallas); one group of patients was random-
ized to antimicrobial therapy with the addition of heparin,
others were assigned to antibiotics alone [6]. Duration of
fever and hospital stay was similar in both groups. Further-
more, neither thromboembolic events nor reinfection were
reported [3].TheBrownetalstudydoesnotsupporttheem-
piric use of anticoagulants for SPT.
Antibiotic management follows the experience of Di
Zerega et al (1979), who determined that response to Clin-
damycin and Gentamycin in women with endometritis fol-
lowing a cesarean delivery was adequate [8]. Since then,
many comparative studies with novel single and multiagent
antibiotic therapies failed to demonstrate superior eﬃcacy.
In 1988 Walmer et al associated failure of the Clindamycin-
Gentamycin combination with enterococcal infection. Addi-
tion of ampicillin resulted in the “triple antibiotic regimen”
model. Most institutions recommend this regimen for treat-
ment of puerperal infections; however, if fever persists after 5
days of antibiotics, it is suggested to use an alternative antibi-
otic agent. Imipenem or ertapenem, with its broad spectrum
and anti-pseudomonal activity, represent a reasonable selec-
tion.
The incidence of septic pelvic thrombophlebitis is likely
to rise, as the cesarean section rates continue to climb. It
is still recommended to treat this entity with broad spec-
trum antibiotics. Nevertheless, there are no recommenda-
tions available to guide physicians in regards to anticoagu-
lation therapy. Only heparin use has been described but is
controversial as seen by Brown et al study [3]. However, for
those who prescribe anticoagulant therapy, can low molec-
ular weight heparin anticoagulation therapy be used instead
of unfractionated heparin? How long should the patient be4 Infectious Diseases in Obstetrics and Gynecology
anticoagulated? Is there a role for anticoagulation with oral
warfarin? Is there a role of anticoagulation therapy in the
managementofsepticpelvicthrombophlebitis?Thesearethe
questionsforwhichthereareno answersyetandfurtherran-
domized studies should be done.
In our retrospective review, we have had the experience
of successfully managing eight cases of septic pelvic throm-
bophlebitis over the last 2 years. We used anticoagulation
therapy in all cases in addition to broad spectrum antibiotic
therapy. When patients did not respond to broad spectrum
antibiotics after 5 days, SPT was suspected, anticoagulation
wasinitiatedwithsubcutaneousenoxaparinandaCTscanor
MRI of the pelvis was ordered. If the imaging showed a small
pelvic thrombosed vessel, therapeutic enoxaparin would be
continued for 2 weeks. If the pelvic imaging was negative,
then therapeutic enoxaparin was given only for 1 week. The
only instance were a patient was converted to oral warfarin
and maintained in therapeutic dosage for 3 months was if
a right ovarian vein thrombosis was seen. A follow up with
pelvic MRI was done 3 months after treatment. The cases
that we managed ﬁt into the three categories described in
Table 1.
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